Bibliographie (2546)
Study shows the viral loads in the Delta infections are ~1000 times higher than those in the earlier strain infections on the day when viruses are firstly detected.
jeudi, 15 juillet 2021 14:49 Écrit par Zouhair SouissiViral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant – Virological.org Commentary: The Delta Variant Isn’t Just Hyper-Contagious. It Also Grows More Rapidly Inside You – NPR Related: WHO: Delta variant is ‘most transmissible’ identified so far. AND Increased transmissibility and global spread of SARS-CoV-2 variants of concern – […]
The post Study shows the viral loads in the Delta infections are ~1000 times higher than those in the earlier strain infections on the day when viruses are firstly detected. appeared first on Links Medicus.
RCT: Bamlanivimab plus Etesevimab reduce mortality and hospitalization in ambulatory patients with early Covid-19 (within 3 days of a positive test) who are at risk for clinical deterioration (i.e., older people, obese, diabetics, immunocompromised, with
jeudi, 15 juillet 2021 14:49 Écrit par Zouhair SouissiBamlanivimab plus Etesevimab in Mild or Moderate Covid-19 – New England Journal of Medicine
The post RCT: Bamlanivimab plus Etesevimab reduce mortality and hospitalization in ambulatory patients with early Covid-19 (within 3 days of a positive test) who are at risk for clinical deterioration (i.e., older people, obese, diabetics, immunocompromised, with CV disease). appeared first on Links Medicus.
Sarcoidosis: A clinical overview from symptoms to diagnosis.
jeudi, 15 juillet 2021 11:17 Écrit par Zouhair SouissiSarcoidosis: A Clinical Overview from Symptoms to Diagnosis – Cells
The post Sarcoidosis: A clinical overview from symptoms to diagnosis. appeared first on Links Medicus.
Real-World Evidence: The low validity of temperature screening for COVID-19 triage.
mercredi, 14 juillet 2021 14:00 Écrit par Zouhair SouissiReal-World Evidence: The Low Validity of Temperature Screening for COVID-19 Triage – Frontiers in Public Health Commentary on Twitter Temperature screening with infrared thermometers has a sensitivity of 9.43% for PCR+ COVID. https://t.co/GjaKpkUqwU — Carlos del Rio (@CarlosdelRio7) July 7, 2021
The post Real-World Evidence: The low validity of temperature screening for COVID-19 triage. appeared first on Links Medicus.
Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.
mercredi, 14 juillet 2021 14:00 Écrit par Zouhair SouissiBetween BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women – JAMA Commentary: Pfizer COVID vaccine shows 78% efficacy in pregnancy – CIDRAP
The post Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy. appeared first on Links Medicus.
One COVID vaccine dose yields good protection in elderly, 2 studies find.
mercredi, 14 juillet 2021 14:00 Écrit par Zouhair SouissiOne COVID vaccine dose yields good protection in elderly, 2 studies find – CIDRAP Original study 1: Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study – The Lancet Infectious Diseases Original Study 2: Effectiveness of BNT162b2 […]
The post One COVID vaccine dose yields good protection in elderly, 2 studies find. appeared first on Links Medicus.
RCT: Neither Remdesivir nor Hydroxychloroquine affect viral clearance in hospitalized patients with COVID-19.
mercredi, 14 juillet 2021 14:00 Écrit par Zouhair SouissiNews release: Neither remdesivir nor HCQ affect viral clearance in hospitalized patients with COVID-19 – American College of Physicians Original Study: Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 – Annals of Internal Medicine Commentary on Twitter Newly published research in Annals concludes neither remdesivir nor #hydroxychloroquine affected viral […]
The post RCT: Neither Remdesivir nor Hydroxychloroquine affect viral clearance in hospitalized patients with COVID-19. appeared first on Links Medicus.
Opinion | The case for mandating COVID-19 vaccines for health care workers.
mercredi, 14 juillet 2021 14:00 Écrit par Zouhair SouissiThe Case for Mandating COVID-19 Vaccines for Health Care Workers – Annals of Internal Medicine News release: Case is strong for mandating COVID-19 vaccination for health care workers – American College of Physicians Commentary on Twitter The Case for Mandating COVID-19 Vaccines for Health Care Workers https://t.co/pdaBRZdkfG via @AnnalsofIM "The case for mandating SARS-CoV-2 […]
The post Opinion | The case for mandating COVID-19 vaccines for health care workers. appeared first on Links Medicus.
RCT: Lopinavir-ritonavir and hydroxychloroquine worsened outcomes in critically ill patients with COVID-19.
mercredi, 14 juillet 2021 14:00 Écrit par Zouhair SouissiLopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial – Intensive Care Medicine Commentary on Twitter (thread – click for more) Results of @remap_cap #Covid_19 #Antiviral Domain released Online First @yourICM: Among critically ill patients with COVID-19, #lopinavir-ritonavir, #HydroxyChloroquine, or combination therapy worsened outcomes compared to no antiviral therapy — […]
The post RCT: Lopinavir-ritonavir and hydroxychloroquine worsened outcomes in critically ill patients with COVID-19. appeared first on Links Medicus.
M-A: Similar mortality with Fluoroquinolones or Macrolides for the treatment of Legionella Pneumonia.
mardi, 13 juillet 2021 12:43 Écrit par Zouhair SouissiAre Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis – Clinical Infectious Diseases (link to abstract – $ for full-text)
The post M-A: Similar mortality with Fluoroquinolones or Macrolides for the treatment of Legionella Pneumonia. appeared first on Links Medicus.
![[Preprint] Long Covid: Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people.](/media/k2/items/cache/2afca3f53c0e96b8eb32503314e80c62_XS.jpg)
